MENU
CGON
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CG Oncology (CGON) Ownership - Who owns CG Oncology?
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more
Profile
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.64B
P/E Ratio
N/A
Total Cash
540.71M
Projected Growth
N/A
Total Debt
296K
Revenue
684K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.09
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
CGON
Capitalization
1.64B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
541M
Total Cash/Share
7.09
Total Debt
296K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
684K
ROE
N/A
Book Value
537M
P/B Ratio
2.24
Cash Flow
N/A
Earnings
-15.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
35.32
Current Revenue Per Employee
704.92
Dividends Per Share - Security
N/A
EBITDA
-95.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.60
Shares Held By Institutions
2.46B
Shares Outstanding - Current
76.2M
Total Liabilities
15.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-24.965
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com